// App-Quantinova.ai

: Periprocedural Interruption of Anticoagulation in Patients with Cancer-Associated VTE: An Analysis of Thrombotic and Bleeding Outcomes

Researchers

Presenter

  • Joseph R. Shaw

Principal Investigators

  • James Douketis

  • Gregoire Le Gal

  • Marc Carrier

Medical Centers

  • Univ of Ottawa, Ottawa, Canada

  • Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Canada

  • University of Ottawa, and Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

  • Heparin

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved